Principal Financial Group Inc. Invests $248,000 in National Research Co. (NASDAQ:NRC)

Principal Financial Group Inc. acquired a new stake in shares of National Research Co. (NASDAQ:NRC) during the third quarter, HoldingsChannel reports. The fund acquired 10,857 shares of the company’s stock, valued at approximately $248,000.

A number of other hedge funds also recently bought and sold shares of NRC. Russell Investments Group Ltd. raised its stake in shares of National Research by 6.3% during the first quarter. Russell Investments Group Ltd. now owns 14,348 shares of the company’s stock worth $568,000 after acquiring an additional 847 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of National Research by 1.1% during the 1st quarter. Vanguard Group Inc. now owns 944,995 shares of the company’s stock valued at $37,431,000 after purchasing an additional 10,351 shares during the last quarter. BOKF NA purchased a new position in National Research in the 1st quarter worth $243,000. Price T Rowe Associates Inc. MD lifted its stake in National Research by 57.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,686 shares of the company’s stock worth $503,000 after purchasing an additional 4,637 shares during the last quarter. Finally, CWM LLC boosted its position in National Research by 889.7% during the second quarter. CWM LLC now owns 1,158 shares of the company’s stock valued at $27,000 after buying an additional 1,041 shares during the period. Institutional investors own 47.26% of the company’s stock.

National Research Stock Up 2.7 %

NRC opened at $19.64 on Tuesday. National Research Co. has a 12 month low of $17.62 and a 12 month high of $42.18. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30. The business’s 50-day moving average price is $19.91 and its 200-day moving average price is $22.99. The company has a market cap of $461.15 million, a P/E ratio of 17.38 and a beta of 0.51.

National Research (NASDAQ:NRC) last posted its quarterly earnings results on Friday, October 25th. The company reported $0.24 earnings per share (EPS) for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The business had revenue of $35.82 million for the quarter.

National Research Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.44%. National Research’s dividend payout ratio is currently 42.48%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.